It has been shown that monotherapy with metformin prevented the development of SLE through reduction in CD4+ T cell activation, expansion of germinal centre Tfh and B cells, serum antinuclear antibody (ANA) level and severity of lupus nephritis. This evidence concerns the gene CD4 and systemic lupus erythematosus.